瑞典Regassa试验子分析:基线酒精摄入对抑郁症患者3年精神科与阿片类药物使用及医疗利用的影响
Subgroup analyses by baseline alcohol consumption of 3-year psychotropic and opioid use and healthcare utilization in patients treated for depression
基于瑞典Regassa随机对照试验的929名抑郁症患者数据显示,报告危险酒精摄入量的人群虽就诊次数较少,但被处方精神科药物的比例更高。在服药患者中,两组间药物剂量无显著差异,但危险酒精摄入组阿片类处方水平较低且疼痛诊断就诊较少。研究建议临床评估抑郁症时应筛查酒精摄入及疼痛状况。
- Article
- Open access
- Published: 23 October 2026
Scientific Reports (2026) Cite this article
We’re sharing this article early to provide faster access to peer-reviewed, accepted research. It is citable and carries a permanent DOI. This version is subject to further edits and will be replaced automatically by the final Version of Record. All legal disclaimers apply.
Abstract
This three-year follow-up study on secondary subgroups embedded in a Swedish randomized controlled trial, Regassa, investigated whether hazardous alcohol consumption influences health care utilization and use of psychotropics and opioids among patients with depression who received treatment for depression but no intervention targeting alcohol use. The cohort of 929 patients was divided into patients reporting hazardous and patients reporting non-hazardous alcohol consumption. Three-year follow-up, registry data on primary and specialized care utilization, as well as dispensed psychotropic and opioid medication were added. Differences in prevalence between the groups were analysed using Prevalence Proportion Ratios and differences in the number of consultations were analyzed using Poisson regression. Medication dispenses and defined daily doses (DDD) were analyzed with a two-step model (1) logistic regression presented as odds ratios (OR) (2) negative binomial regression, presented as incidence rate ratios (IRR). Most participants were women and hazardous alcohol use was reported by 22%, predominantly men. Patients reporting hazardous consumption seemed more likely to be prescribed psychotropics despite fewer health care visits, but among users there were no differences between the groups regarding the amount of medication. Over time, there was a tendency they had lower levels of prescribed opioids and less visits for pain diagnosis. Patients with hazardous alcohol consumption and concurrent depression seem to be prescribed psychotropics more often. These findings may be relevant for clinicians in health care settings when assessing patients with depression to also screen for alcohol consumption and pain and offer tailored and effective interventions.
Abbreviations
- ATC:
-
Anatomical Therapeutic Chemical
- AUDIT:
-
Alcohol Use Disorder Identification Test
- DDD:
-
Daily Defined Dose
- GP:
-
General Practitioner
- iCBT:
-
Internet-based Cognitive Behavioral Therapy
- ICD-10:
-
International Classification of Disorders
- LCL:
-
Lower Confidence Limits
- MADRS:
-
Montgomery Åsberg Depression Rating Scale
- PE:
-
Physical Exercise
- PHQ-9:
-
Patient Health Questionnaire
- PPR:
-
Prevalence Proportion Ratios
- RCT:
-
Randomized Control Trial
- RR:
-
Ratio Rate
- TAU:
-
Treatment as Usual
- UCL:
-
Upper Confidence Limits
Funding
Open access funding provided by Lund University. There is no funding to declare for this study.
Author information
Authors and Affiliations
Department of Psychology, Lund University, Lund, Sweden
Catharina Strid
Department of Global Public Health, Karolinska Institutet, Stockholm, Sweden
Andreas Lundin & Yvonne Forsell
Department of Clinical Sciences, Psychiatry, Lund University, Lund, Sweden
Agneta Öjehagen
Authors
- Catharina Strid
- Andreas Lundin
- Yvonne Forsell
- Agneta Öjehagen
Corresponding author
Correspondence to Catharina Strid.
Ethics declarations
Competing interests
There is no competing interest to declare.
Ethics approval
The study was performed in compliance with relevant laws and guidelines. All patients provided oral and written informed consent before participating. The original Regassa RCT study was before the study started, registered with the registry of clinical trials in Stockholm County, Sweden (KCTR study ID: KT20110063). This registry closed, and the trial was retrospectively registered 10-06-2015 in the German Clinical Trial Register (DRKS study ID: DRKS00008745). The RCT study was approved by the Regional Ethical Review Board in Stockholm, Sweden Dnr 2010/1779-31/4. This registry study included an option-out for the original participants approved by the Regional Ethical Review Board in Stockholm, Sweden, Dnr 2015/2112-31.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Strid, C., Lundin, A., Forsell, Y. et al. Subgroup analyses by baseline alcohol consumption of 3-year psychotropic and opioid use and healthcare utilization in patients treated for depression. Sci Rep (2026). https://doi.org/10.1038/s41598-026-76635-1
Received: 26 November 2025
Accepted: 14 October 2026
Published: 23 October 2026
DOI: https://doi.org/10.1038/s41598-026-76635-1
来源:Nature 健康护理主题 · nature.com